Vaccines Protect Against Multiple Variants, Additional Studies Suggest

Doctor with mask on holding COVID-19 Vaccine

The Pfizer and Moderna coronavirus vaccines are highly effective against and prevent illness from common variants of the virus, according to recently released studies.

The vaccine made by Pfizer is effective against the coronavirus variants that originated from the U.K. and South Africa, according to multiple studies released Wednesday that examined real-world vaccinations, The New York Times reported. Moderna reported that an early-stage trial suggested its vaccine is effective against the South African variant and a third variant originating from Brazil when given as a single-dose booster shot.

“At this point in time, we can confidently say that we can use this vaccine, even in the presence of circulating variants of concern,” London School of Hygiene and Tropical Medicine infectious disease researcher Annelies Wilder-Smith told the NYT.

Read More

Pfizer Says Its Vaccine Significantly Halts COVID-19’s Spread, Effective Against UK Variant

Pfizer said Wednesday that real-world data suggests its coronavirus vaccine is 94% effective in halting asymptomatic infections and effective against a highly transmissible variant first discovered in the United Kingdom.

Israeli analysis of vaccine distribution shows the vaccine being over 97% effective in preventing symptomatic cases and death, higher than the 90% efficiency that was reported in the vaccine’s Phase III trials, Pfizer said in a press release Thursday. Over 80% of the tested specimens were against the UK variant known as B.1.1.7.

Read More

Gov. DeWine Releases First-Round Shot Schedule for Ohio Schools

COLUMBUS, Ohio – Ohio Governor Michael DeWine (R) announced on Friday the vaccination schedule for Ohio K-12 schools – public, private and career-tech.

DeWine’s administration identified school personnel required for in-person learning and laid out a four-week schedule for those eligible to receive their first jab containing one of the vaccines the U.S. Food and Drug Administration has granted authorization for emergency use – Pfizer-BioNTech and Moderna.

Read More

Ohio Governor DeWine Delivers Update on State Response to COVID

Governor DeWine held a 90-minute briefing during which Lt. Governor Jon Husted and Ohio Department of Health Chief Medical Officer Dr. Bruce Vanderhoff contributed.

The following information was relayed by the trio during the Tuesday session.

Read More